In this report, the EMEA Transdermal Patch Market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
A transdermal patch is a type of medical adhesive that is developed to deliver specific doses of drugs present in suspension in the matrix. This matrix is sandwiched between a release liner and a backing film and is easy to use. These patches deliver the drug through the skin by using diffusion techniques and are widely used for the treatment of hormonal and cardiac disorders. Moreover, these patches can also be used for the treatment of Parkinson's disease, Alzheimers, HIV, strokes, dermatology-related conditions, osteoporosis, migraine, and restless leg syndrome treatments. The transdermal patch is available in an active and passive system.
Growing cases of cardiac disorder coupled with the neurological syndrome are expected to propel the growth of the EMEA transdermal patch market. According to the European Heart Network AISB, in 2015, there were just under 11.3 million new cases of CVD in Europe and 6.1 million new cases of CVD in the European Union. Moreover, each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU).
Among Europe, the Middle East and Africa, Europe are projected to gain significant growth over the forecast period and this can be attributed to the rising number of partnerships in the region to produce more transdermal patch due to high demand for these patches. For instance, in September 2018, Nemaura Pharma announced it has entered into a license agreement with a Global Pharma Company to develop 3 new transdermal patch products. These patches address a multi-Billion dollar market and the agreement reflects the confidence placed in Nemaura’s ability to deliver complex dosage formulations.
Key Developments:
- In September 2016, Medherant, a spin-out of the University of Warwick (UK) developing a novel transdermal drug delivery patch technology, has completed a funding round worth £1.5 million, including a direct investment of £650,000 from Mercia Technologies PLC.
- In July 2018, Aequus Pharmaceuticals Inc. (AQS), is pleased to announce a recent expansion of the market opportunity for its reformulated anti-nausea transdermal patch, AQS1303, into the European market.
- In May 2017, The German health authorities have granted LTS’ whole-owned affiliate partner Innovative Injections-Systeme (IIS) its first permit to manufacture transdermal microarrays and microarray-patches in Europe.
- E Ink Holdings and LTS Lohmann-Therapie Systeme AG, "LTS" leading in the development and manufacturing of transdermal therapeutic systems, have announced their partnership to develop a "Smart Patch" prototype. The Smart Patch prototype is a transdermal therapeutic system (TTS) that provides medication to patients in a convenient, controlled and comfortable manner.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Million Units), revenue (Million USD), market share and growth rate of Transdermal Patch for these regions, from 2014 to 2025 (forecast)
⤍ Europe: Germany, France, UK, Russia, Italy and Benelux;
⤍ Middle East: Saudi Arabia, Israel, UAE and Iran;
⤍ Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Transdermal Patch market competition by top manufacturers/players, with Transdermal Patch sales volume (Million Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
⤍ Hisamitsu Pharmaceutical
⤍ Novartis
⤍ Johnson & Johnson
⤍ Teikoku Pharma
⤍ Mylan
⤍ Actavis
⤍ Mundipharma
⤍ Henan Lingrui Pharmaceutical
⤍ Changzhou Siyao
⤍ Rfl Pharmaceutical
On the basis of product, this report displays the sales volume (Million Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
⤍ Fentanyl Transdermal Patch
⤍ Nicotine Transdermal Patch
⤍ Clonidine Transdermal Patch
⤍ Buprenorphine Transdermal Patch
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (Million Units), market share and growth rate of Transdermal Patch for each application, including
⤍ Relieve Severe Pain
⤍ Stop Smoking Cigarettes
⤍ Treat An Overactive Bladder
⤍ Others
**If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
EMEA (Europe, Middle East and Africa) Transdermal Patch Market Report 2019
1 Transdermal Patch Overview
1.1 Product Overview and Scope of Transdermal Patch
1.2 Classification of Transdermal Patch
1.2.1 EMEA Transdermal Patch Market Size (Sales) Comparison by Type (2014-2025)
1.2.2 EMEA Transdermal Patch Market Size (Sales) Market Share by Type (Product Category) in 2018
1.2.3 Fentanyl Transdermal Patch
1.2.4 Nicotine Transdermal Patch
1.2.5 Clonidine Transdermal Patch
1.2.6 Buprenorphine Transdermal Patch
1.3 EMEA Transdermal Patch Market by Application/End Users
1.3.1 EMEA Transdermal Patch Sales (Volume) and Market Share Comparison by Application (2014-2025
1.3.2 Relieve Severe Pain
1.3.3 Stop Smoking Cigarettes
1.3.4 Treat An Overactive Bladder
1.3.5 Others
1.4 EMEA Transdermal Patch Market by Region
1.4.1 EMEA Transdermal Patch Market Size (Value) Comparison by Region (2014-2025)
1.4.2 Europe Status and Prospect (2014-2025)
1.4.3 Middle East Status and Prospect (2014-2025)
1.4.4 Africa Status and Prospect (2014-2025)
1.5 EMEA Market Size (Value and Volume) of Transdermal Patch (2014-2025)
1.5.1 EMEA Transdermal Patch Sales and Growth Rate (2014-2025)
1.5.2 EMEA Transdermal Patch Revenue and Growth Rate (2014-2025)
2 EMEA Transdermal Patch Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Transdermal Patch Market Competition by Players/Manufacturers
2.1.1 EMEA Transdermal Patch Sales Volume and Market Share of Major Players (2014-2019)
2.1.2 EMEA Transdermal Patch Revenue and Share by Players (2014-2019)
2.1.3 EMEA Transdermal Patch Sale Price by Players (2014-2019)
2.2 EMEA Transdermal Patch (Volume and Value) by Type/Product Category
2.2.1 EMEA Transdermal Patch Sales and Market Share by Type (2014-2019)
2.2.2 EMEA Transdermal Patch Revenue and Market Share by Type (2014-2019)
2.2.3 EMEA Transdermal Patch Sale Price by Type (2014-2019)
2.3 EMEA Transdermal Patch (Volume) by Application
2.4 EMEA Transdermal Patch (Volume and Value) by Region
2.4.1 EMEA Transdermal Patch Sales and Market Share by Region (2014-2019)
2.4.2 EMEA Transdermal Patch Revenue and Market Share by Region (2014-2019)
2.4.3 EMEA Transdermal Patch Sales Price by Region (2014-2019)
3 Europe Transdermal Patch (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Transdermal Patch Sales and Value (2014-2019)
3.1.1 Europe Transdermal Patch Sales Volume and Growth Rate (2014-2019)
3.1.2 Europe Transdermal Patch Revenue and Growth Rate (2014-2019)
3.2 Europe Transdermal Patch Sales and Market Share by Type
3.3 Europe Transdermal Patch Sales and Market Share by Application
3.4 Europe Transdermal Patch Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Transdermal Patch Sales Volume by Countries (2014-2019)
3.4.2 Europe Transdermal Patch Revenue by Countries (2014-2019)
3.4.3 Germany Transdermal Patch Sales and Growth Rate (2014-2019)
3.4.4 France Transdermal Patch Sales and Growth Rate (2014-2019)
3.4.5 UK Transdermal Patch Sales and Growth Rate (2014-2019)
3.4.6 Russia Transdermal Patch Sales and Growth Rate (2014-2019)
3.4.7 Italy Transdermal Patch Sales and Growth Rate (2014-2019)
3.4.8 Benelux Transdermal Patch Sales and Growth Rate (2014-2019)
4 Middle East Transdermal Patch (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Transdermal Patch Sales and Value (2014-2019)
4.1.1 Middle East Transdermal Patch Sales Volume and Growth Rate (2014-2019)
4.1.2 Middle East Transdermal Patch Revenue and Growth Rate (2014-2019)
4.2 Middle East Transdermal Patch Sales and Market Share by Type
4.3 Middle East Transdermal Patch Sales and Market Share by Application
4.4 Middle East Transdermal Patch Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Transdermal Patch Sales Volume by Countries (2014-2019)
4.4.2 Middle East Transdermal Patch Revenue by Countries (2014-2019)
4.4.3 Saudi Arabia Transdermal Patch Sales and Growth Rate (2014-2019)
4.4.4 Israel Transdermal Patch Sales and Growth Rate (2014-2019)
4.4.5 UAE Transdermal Patch Sales and Growth Rate (2014-2019)
4.4.6 Iran Transdermal Patch Sales and Growth Rate (2014-2019)
5 Africa Transdermal Patch (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Transdermal Patch Sales and Value (2014-2019)
5.1.1 Africa Transdermal Patch Sales Volume and Growth Rate (2014-2019)
5.1.2 Africa Transdermal Patch Revenue and Growth Rate (2014-2019)
5.2 Africa Transdermal Patch Sales and Market Share by Type
5.3 Africa Transdermal Patch Sales and Market Share by Application
5.4 Africa Transdermal Patch Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Transdermal Patch Sales Volume by Countries (2014-2019)
5.4.2 Africa Transdermal Patch Revenue by Countries (2014-2019)
5.4.3 South Africa Transdermal Patch Sales and Growth Rate (2014-2019)
5.4.4 Nigeria Transdermal Patch Sales and Growth Rate (2014-2019)
5.4.5 Egypt Transdermal Patch Sales and Growth Rate (2014-2019)
5.4.6 Algeria Transdermal Patch Sales and Growth Rate (2014-2019)
6 EMEA Transdermal Patch Manufacturers/Players Profiles and Sales Data
6.1 Hisamitsu Pharmaceutical
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Transdermal Patch Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Novartis
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Transdermal Patch Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis Transdermal Patch Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Transdermal Patch Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Johnson & Johnson Transdermal Patch Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 Teikoku Pharma
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Transdermal Patch Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Teikoku Pharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 Mylan
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Transdermal Patch Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Mylan Transdermal Patch Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 Actavis
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Transdermal Patch Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Actavis Transdermal Patch Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
6.7 Mundipharma
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Transdermal Patch Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Mundipharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Main Business/Business Overview
6.8 Henan Lingrui Pharmaceutical
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Transdermal Patch Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Henan Lingrui Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2014-2019)
6.8.4 Main Business/Business Overview
6.9 Changzhou Siyao
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Transdermal Patch Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Changzhou Siyao Transdermal Patch Sales, Revenue, Price and Gross Margin (2014-2019)
6.9.4 Main Business/Business Overview
6.10 Rfl Pharmaceutical
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Transdermal Patch Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Rfl Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2014-2019)
6.10.4 Main Business/Business Overview
7 Transdermal Patch Manufacturing Cost Analysis
7.1 Transdermal Patch Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Transdermal Patch
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Transdermal Patch Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Transdermal Patch Major Manufacturers in 2018
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Transdermal Patch Market Forecast (2019-2025)
11.1 EMEA Transdermal Patch Sales, Revenue and Price Forecast (2019-2025)
11.1.1 EMEA Transdermal Patch Sales and Growth Rate Forecast (2019-2025)
11.1.2 EMEA Transdermal Patch Revenue and Growth Rate Forecast (2019-2025)
11.1.3 EMEA Transdermal Patch Price and Trend Forecast (2019-2025)
11.2 EMEA Transdermal Patch Sales, Revenue and Growth Rate Forecast by Region (2019-2025)
11.3 Europe Transdermal Patch Sales, Revenue and Growth Rate Forecast by Region (2019-2025)
11.4 Middle Eastt Transdermal Patch Sales, Revenue and Growth Rate Forecast by Region (2019-2025)
11.5 Africa Transdermal Patch Sales, Revenue and Growth Rate Forecast by Region (2019-2025)
11.6 EMEA Transdermal Patch Sales Forecast by Type (2019-2025)
11.7 EMEA Transdermal Patch Sales Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Request Discount 
Inquire Before Buy
